TNFRSF1B +676 T>G polymorphism predicts survival of non-Small cell lung cancer patients treated with chemoradiotherapy
暂无分享,去创建一个
Q. Wei | D. Gomez | R. Komaki | Z. Liao | Zhensheng Liu | Hongxia Ma | J. Qian | X. Guan | Xianglin Yuan | Li‐E. Wang | Q. Wei | Hongxia Ma
[1] Caicun Zhou,et al. Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with treatment response and survival , 2011, Medical Oncology.
[2] A. Jemal,et al. Global Cancer Statistics , 2011 .
[3] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[4] A. Kuwahara,et al. TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma , 2010, Journal of experimental & clinical cancer research : CR.
[5] Lei Yao,et al. TNFα −308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls , 2010, Breast Cancer Research and Treatment.
[6] R. D. Mittal,et al. Association of tumour necrosis factor‐α gene (T‐1031C, C‐863A, and C‐857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette‐Guérin immunotherapy , 2009, BJU international.
[7] J. Kładny,et al. Clinical characteristics of tumors derived from colorectal cancer patients who harbor the tumor necrosis factor alpha-1031T/T and NOD2 3020insC polymorphism. , 2009, Cancer epidemiology.
[8] M. Martel,et al. Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] E. Nkenke,et al. Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer. , 2009, Anticancer research.
[10] Jack A. Taylor,et al. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies , 2009, Nucleic Acids Res..
[11] A. Tomovic,et al. TNF-alpha-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer. , 2009, Neoplasma.
[12] Manuela Zucknick,et al. Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer. , 2008, Clinical colorectal cancer.
[13] Satya N. Das,et al. Association of TNF-alpha and TNFR1 promoters and 3' UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians. , 2008, Oral oncology.
[14] Lujun Zhao,et al. Inhibition of the Tumor Necrosis Factor-α Pathway Is Radioprotective for the Lung , 2008, Clinical Cancer Research.
[15] L. Larocca,et al. Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] M. Collado,et al. Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis. , 2007, Human immunology.
[17] S. Chanock,et al. Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF–LTA) and breast cancer risk , 2007, Human Genetics.
[18] V. Baniasadi,et al. Association of −308 TNF‐α promoter polymorphism with type 1 diabetes in North Indians , 2006 .
[19] I. Endo,et al. Predicting 5‐fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: Three‐gene expression model predicts clinical response , 2006, International journal of cancer.
[20] G. Fontanini,et al. Tumour necrosis factor-α: prognostic role and relationship with interleukin-8 and endothelin-1 in non-small cell lung cancer , 2006 .
[21] Wei Chen,et al. Association of TNF-α polymorphism with susceptibility to and severity of non-small cell lung cancer , 2006 .
[22] G. Fontanini,et al. Tumour necrosis factor-alpha: prognostic role and relationship with interleukin-8 and endothelin-1 in non-small cell lung cancer. , 2006, International journal of molecular medicine.
[23] M. Chou,et al. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. , 2006, Lung cancer.
[24] V. Baniasadi,et al. Association of -308 TNF-alpha promoter polymorphism with type 1 diabetes in North Indians. , 2006, International journal of immunogenetics.
[25] D. Gandara,et al. Integration of Novel Therapeutics into Combined Modality Therapy of Locally Advanced Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.
[26] L. Chouchane,et al. A functional polymorphism of the tumor necrosis factor receptor-II gene associated with the survival and relapse prediction of breast carcinoma. , 2005, Cytokine.
[27] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[28] P. Rosenstiel,et al. The Met-196 → Arg Variation of Human Tumor Necrosis Factor Receptor 2 (TNFR2) Affects TNF-α-induced Apoptosis by Impaired NF-κB Signaling and Target Gene Expression* , 2005, Journal of Biological Chemistry.
[29] Wun-Jae Kim,et al. Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. , 2005, Urology.
[30] P. Rosenstiel,et al. The Met-196 -> Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression. , 2005, The Journal of biological chemistry.
[31] M. Stolte,et al. Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] Wun-Jae Kim,et al. Association of bladder tumors and GA genotype of -308 nucleotide in tumor necrosis factor-alpha promoter with greater tumor necrosis factor-alpha expression. , 2004, Urology.
[33] A. Bateman,et al. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. , 2004, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[34] T. Ottenhoff,et al. Is there a future for TNF promoter polymorphisms? , 2004, Genes and Immunity.
[35] G. Jackson,et al. Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation1 , 2003, Transplantation.
[36] B. Aggarwal. Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.
[37] C. Caldas,et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. , 2003, Gastroenterology.
[38] N. Willich,et al. Modulation of radiation-induced tumour necrosis factor α (TNF-α) expression in the lung tissue by pentoxifylline , 2002 .
[39] F. Greene. The American Joint Committee on Cancer: updating the strategies in cancer staging. , 2002, Bulletin of the American College of Surgeons.
[40] N. Willich,et al. Modulation of radiation-induced tumour necrosis factor alpha (TNF-alpha) expression in the lung tissue by pentoxifylline. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[41] T. Horiuchi,et al. Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis. , 2001, Arthritis and rheumatism.
[42] A. Hajeer,et al. Influence of TNFa gene polymorphisms on TNFa production and disease , 2001 .
[43] R. Tsuchiya,et al. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. , 2001, The Annals of thoracic surgery.
[44] J. Chun,et al. The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. , 2001, Cancer letters.
[45] S. Remadi,et al. Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. , 2001, Cancer.
[46] A. Hajeer,et al. Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. , 2001, Human immunology.
[47] A. Hajeer,et al. TNF‐α gene polymorphism: Clinical and biological implications , 2000 .
[48] C. Angeletti,et al. Tumour necrosis factor- α and transforming growth factor- β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL -2-mediated neovascularization , 2000, British Journal of Cancer.
[49] A. Hajeer,et al. TNF-alpha gene polymorphism: clinical and biological implications. , 2000, Microscopy research and technique.
[50] T. Shimosegawa,et al. Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene. , 1999, Gastroenterology.
[51] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[52] B. Kallakury,et al. Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma , 1998, Cancer.
[53] S. Fox,et al. Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. , 1998, British Journal of Cancer.
[54] M. Hibberd,et al. Genetic influence on cytokine production in meningococcal disease , 1997, The Lancet.
[55] H. Mcdevitt,et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[56] D. Goeddel,et al. Physical mapping and genomic structure of the human TNFR2 gene. , 1996, Genomics.
[57] D. Miles,et al. Expression of tumour necrosis factor (TNFα) and its receptors in benign and malignant breast tissue , 1994 .
[58] L. Tartaglia,et al. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. , 1993, The Journal of biological chemistry.
[59] W. Foulkes,et al. Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. , 1993, The Journal of clinical investigation.